Video

Dr Brett McQueen: Multiple-Criteria Decision Analysis Can Aid in Reimbursement, Coverage Decisions

R. Brett McQueen, PhD, assistant professor, Department of Clinical Pharmacy, Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado, explains how multiple-criteria decision analysis be used to aid in coverage and reimbursement decisions for high-cost, innovative therapies.

R. Brett McQueen, PhD, assistant professor, Department of Clinical Pharmacy, Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado, explains how multiple-criteria decision analysis be used to aid in coverage and reimbursement decisions for high-cost, innovative therapies.

Transcript

How can multiple-criteria decision analysis be used to aid in coverage and reimbursement decisions for high-cost, innovative therapies?

MCDA [multiple-criteria decision analysis] provides a structure to quantify preferences for multiple stakeholders but it can also help incentivize evidence generation in these novel spaces in which with traditional value assessment, we haven’t focused on evidence generation in the nontraditional, so it helps not only bring stakeholders together but also incentivize that evidence generation process, which is very important for coverage and reimbursement decision making.

What are best practices for successfully implementing MCDA and transitioning away from other value assessments?

ISPOR has a best practices guideline and taskforce on MCDA, so we’d urge interested readers to go to the ISPOR website to view that. The idea with pValue is not to transition away from traditional value assessment but rather add to it or complement traditional value assessment.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists
Rachel Rohaidy, MD
Mansi Shah, MD
Miriam Freimer, MD
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Dr Pankit Vachhani
Dr Ibrahim Aldoss
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo